Evidence review · Published July 22, 2026 · Sources checked July 22, 2026

BPC-157 research overview

BPC-157 is a synthetic 15-amino-acid peptide investigated primarily in cell and animal models. The published record cited here is preclinical.

Evidence boundary: published research does not establish the identity or performance of a separately supplied batch. The catalog product is supplied only for qualified in vitro laboratory research and is not for human or animal use.

What is BPC-157?

Cell studies have examined endothelial signaling and tendon-fibroblast migration, while rat experiments have used tendon-injury and other experimental models.

Research category
Tissue & cellular signaling
Study models represented
Human cells ex vivo/in vitro and rat injury models
Names in the literature
Body Protection Compound-157; GEPPPGKPADDAGLV
Primary boundary
The cited evidence is preclinical and has limited independent clinical validation.

What does the selected evidence support?

These studies can support mechanistic hypotheses about VEGFR2-associated signaling and cell behavior. They do not establish human safety, clinical efficacy, or equivalence of a separately manufactured batch.

Primary sources

  1. Hsieh et al., Journal of Molecular Medicine (2017) — Endothelial-cell and animal work examining VEGFR2-associated angiogenic signaling. DOI: 10.1007/s00109-016-1488-y
  2. Chang et al., Journal of Applied Physiology (2011) — Ex vivo and in vitro tendon-fibroblast migration and survival experiments. DOI: 10.1152/japplphysiol.00945.2010
  3. Staresinic et al., Journal of Orthopaedic Research (2003) — Transected rat Achilles-tendon and cultured-tendocyte experiments. DOI: 10.1016/S0736-0266(03)00110-4

Research literature and product documentation are different

A publication describes a study and its results. A batch-specific Certificate of Analysis documents characteristics of a supplied research material. One does not substitute for the other.

Review BPC-157 product specifications · Browse the COA library · Read the research-use policy

Prepared by The Pep Labs Research Editorial Team. This evidence summary is not medical advice and contains no dosing or administration guidance.